Charles River Laboratories

The DMDG -GMP-SPS returns this October, bringing together 3 major European ADME-DMPK organizations in Prague, and we are honored to support this event as Gold sponsors once again. Meet our expert team at Booth #04 to discuss how we can support your program with fit-for-purpose solutions and reliable data, or to learn more about our integrated DMPK-Tox portfolio. Don’t miss our in vitro ADME expert, Tamás Szalai's talk discussing In Vitro DDI Assessment of Advanced Modalities as part of Session 9. Meet the team: https://okt.to/cRdxsG

Laura Lotfi, Director of Digital Scientific Innovation, and Mainity Batista Linhares, Veterinary Pathologist II, were featured in Technology Networks discussing why digital pathology is foundational to the future of nonclinical research and new approach methodologies (NAMs). The article explores how digitized tissue evidence, AI-powered analysis, virtual control groups, and multiomics are bridging traditional pathology with emerging scientific models, creating a more connected, data-driven approach to safety assessment and translational science. Read more here: https://okt.to/7eNkMZ

#EUROTOX2026 showcased the science, innovation, and collaboration shaping the future of toxicology. Learn which trends, research, and discussions stood out most to Joanne Chua, PhD, Senior Director of Toxicology and Pathology, and why they matter for advancing safe and effective therapies.

Don’t miss our featured ESTP session, “Rethinking Pathology Paradigms: Evaluating Digital Whole Slide Imaging Versus Historical Microscopic Data to Build Virtual Control Groups and Advance the 3Rs,” and connect with our experts. https://okt.to/CKOl5N Translational Science Delivered with Certainty. Because Every Moment Matters. #ESTP2026 #toxpath #toxpath #veterinarypathology #digitalpathology #CharlesRiver #translationalscience

The promise of genomic medicines for rare disorders is immense, but current #drugdevelopment models, biomanufacturing technologies, and healthcare systems were not designed to support treatments for the rarest patient populations. That is why ARM, together with more than 20 contributors, including Charles River experts Michael V Templin, Matthew Hewitt, and Lauren E. Black, developed A Platform Framework for Gene Editing Drug Development. The playbook outlines a practical framework for leveraging commonalities across gene editing components, drug products, clinical pathways, and diseases, while recognizing where unique approaches are still required. If we are going to bring potentially curative therapies to patients with ultrarare diseases, alternative development models will be essential. This framework represents an important step toward making that future possible.

What if historical data can help transform a study? Virtual Control Groups (VCGs) are chaning how the industry thinks about control animals in toxicology studies. By combining curated historical data with advanced analytics, researchers can explore new approaches that support scientific rigor while advancing the 3Rs. If you have heard about VCGs but want to understand how they actually work, click the link below. https://okt.to/GqT9jb

One split shell. Two endotoxin testing methods. Meet Evo, inspired by the animal that has stood behind the test for fifty years. https://okt.to/ukoJaH

Growth rarely follows a straight line. For Nicole Moyle, the roles that challenged her most also helped her grow the furthest. Since joining Charles River in 2018 as an Account Manager for Microbial Solutions in Australia, Nicole has moved from active sales into a customer support leadership role. The transition brought new challenges, opportunities to prioritize her wellbeing and the chance to develop as a people leader. Along the way, Nicole has continued to learn, connect and contribute through mentoring, the Australian Community Ambassadors group and the Mental Health and Wellness Employee Resource Group. Discover how embracing change helped Nicole find new opportunities to grow. https://okt.to/arHJR3 #LIFEatCRL #CareerGrowth

From joining Charles River in 1989 to becoming CEO in 2026, Birgit Girshick's career journey is a testament to the power of curiosity, perseverance, and purpose-driven leadership. We're proud to celebrate Birgit's recognition as a 2026 ICON Award honoree by the Boston Business Journal's Women Who Mean Business program. Read more here: https://okt.to/k9f87r

Attending ESTP September 29 to October 2, 2026, in Krakow, Poland? Visit our pathology experts at Booth #3 to discover how you can leverage our scientific expertise and integrated, end-to-end digital workflows for faster, actionable insights. If you’ll be on-site, schedule a meeting ahead of the show or stop by our booth to meet the experts. https://okt.to/DRJ7oz Translational Science Delivered with Certainty. Because Every Moment Matters. #ESTP2026 #toxpath #toxpath #veterinarypathology #digitalpathology #CharlesRiver #translationalscience